Profiles

Keywords
Last Name
Institution

Nancy Reau

Concepts (219)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatitis C, Chronic
27
2021
82
9.510
Why?
Antiviral Agents
30
2021
138
9.160
Why?
Hepatitis C
17
2021
65
6.450
Why?
Hepacivirus
19
2021
71
4.200
Why?
Liver Diseases
9
2021
39
3.530
Why?
Liver Transplantation
7
2021
107
2.950
Why?
Ribavirin
9
2016
32
2.120
Why?
Pregnancy Complications
5
2019
56
2.020
Why?
Liver Cirrhosis
10
2019
61
1.740
Why?
Sulfonamides
7
2020
63
1.560
Why?
Hepatitis B
5
2019
20
1.540
Why?
Pregnancy Complications, Infectious
2
2019
34
1.500
Why?
Polyethylene Glycols
5
2012
55
1.480
Why?
Interferon-alpha
5
2012
82
1.480
Why?
Humans
53
2021
29841
1.200
Why?
Pregnancy
8
2021
443
1.190
Why?
Carbamates
8
2020
9
1.190
Why?
Drug Therapy, Combination
13
2021
264
1.120
Why?
Quinoxalines
4
2020
10
1.110
Why?
Infectious Disease Transmission, Vertical
2
2019
19
1.040
Why?
Gastroenterology
3
2017
16
1.010
Why?
Living Donors
1
2021
16
0.960
Why?
United States
15
2021
2402
0.900
Why?
Thrombocytopenia
1
2020
31
0.900
Why?
Treatment Outcome
19
2021
3788
0.890
Why?
Postoperative Hemorrhage
1
2020
30
0.880
Why?
Benzimidazoles
3
2019
12
0.880
Why?
Elective Surgical Procedures
1
2020
53
0.880
Why?
Kidney Transplantation
2
2018
143
0.840
Why?
Hypertension, Pregnancy-Induced
1
2019
1
0.830
Why?
Genotype
10
2017
435
0.830
Why?
Female
30
2021
17657
0.790
Why?
Viral Load
5
2016
208
0.780
Why?
Algorithms
2
2020
414
0.760
Why?
Fear
1
2018
49
0.760
Why?
Cholestasis, Intrahepatic
3
2019
6
0.760
Why?
Drugs, Generic
1
2016
4
0.690
Why?
HIV Infections
3
2019
902
0.680
Why?
Antacids
1
2016
1
0.680
Why?
Proton Pump Inhibitors
1
2016
15
0.680
Why?
Pregnancy Complications, Neoplastic
1
2016
4
0.670
Why?
Virology
1
2015
16
0.650
Why?
Patient Readmission
1
2016
111
0.600
Why?
Length of Stay
2
2016
360
0.580
Why?
Coinfection
3
2019
33
0.570
Why?
Preventive Health Services
1
2013
15
0.550
Why?
Adult
19
2021
9591
0.540
Why?
Advisory Committees
1
2013
43
0.540
Why?
Health Policy
1
2013
49
0.530
Why?
Middle Aged
20
2020
11053
0.530
Why?
Heart Failure
1
2016
222
0.510
Why?
Disease Management
2
2016
149
0.490
Why?
Liver
2
2018
213
0.480
Why?
Imidazoles
4
2020
72
0.450
Why?
Macrocyclic Compounds
4
2019
6
0.440
Why?
Pregnancy Outcome
2
2021
20
0.440
Why?
Recombinant Proteins
5
2012
306
0.440
Why?
Male
22
2021
17153
0.430
Why?
Drug Resistance, Viral
4
2017
43
0.430
Why?
Bile Ducts, Intrahepatic
1
2008
7
0.380
Why?
Drug Administration Schedule
3
2018
265
0.380
Why?
Aged
14
2020
9833
0.380
Why?
Fatty Liver
2
2019
40
0.360
Why?
Anemia
1
2008
90
0.360
Why?
Retrospective Studies
8
2020
3303
0.360
Why?
Cohort Studies
6
2021
1911
0.360
Why?
Medication Adherence
2
2019
87
0.350
Why?
Liver Neoplasms
2
2019
124
0.340
Why?
Liver Function Tests
2
2019
32
0.330
Why?
Benzofurans
3
2020
6
0.320
Why?
Graft Rejection
2
2018
85
0.310
Why?
Societies, Medical
2
2017
202
0.300
Why?
Drug Interactions
2
2015
71
0.290
Why?
Mass Screening
3
2015
193
0.290
Why?
Cyclopropanes
2
2020
8
0.280
Why?
Incidence
2
2020
813
0.280
Why?
Prospective Studies
4
2019
1809
0.280
Why?
Amides
2
2020
23
0.270
Why?
Uracil
3
2019
5
0.270
Why?
Young Adult
7
2020
2198
0.270
Why?
Ritonavir
3
2019
18
0.270
Why?
Risk Assessment
3
2018
794
0.270
Why?
Prognosis
3
2018
1025
0.260
Why?
Chronic Disease
3
2020
530
0.250
Why?
Fertility
1
2021
15
0.240
Why?
Graft Survival
2
2019
111
0.240
Why?
Aged, 80 and over
8
2020
5016
0.230
Why?
World Health Organization
1
2020
20
0.230
Why?
Cost-Benefit Analysis
3
2019
144
0.230
Why?
Tissue Donors
1
2021
71
0.230
Why?
End Stage Liver Disease
1
2020
17
0.230
Why?
Anilides
2
2019
11
0.220
Why?
Hemorrhage
1
2020
87
0.220
Why?
Recurrence
2
2011
383
0.220
Why?
Consensus
2
2021
90
0.210
Why?
Drug and Narcotic Control
2
2016
8
0.210
Why?
Hyperemesis Gravidarum
1
2019
1
0.210
Why?
Hepatitis, Autoimmune
1
2019
8
0.210
Why?
Carcinoma, Hepatocellular
1
2019
44
0.210
Why?
Forecasting
1
2019
129
0.200
Why?
United States Food and Drug Administration
2
2016
77
0.200
Why?
Biomedical Research
1
2019
85
0.200
Why?
Transplant Recipients
1
2018
18
0.200
Why?
Internationality
1
2018
26
0.190
Why?
Logistic Models
2
2010
478
0.190
Why?
RNA, Viral
3
2018
169
0.190
Why?
Follow-Up Studies
4
2015
2017
0.190
Why?
Practice Guidelines as Topic
3
2021
382
0.190
Why?
Drug Substitution
1
2017
3
0.180
Why?
Critical Pathways
1
2017
23
0.180
Why?
Risk Factors
3
2020
2549
0.180
Why?
Dose-Response Relationship, Drug
1
2018
524
0.180
Why?
Infant, Newborn
1
2019
741
0.180
Why?
Counterfeit Drugs
1
2016
2
0.170
Why?
Patient Participation
1
2017
51
0.170
Why?
Commerce
1
2016
11
0.170
Why?
Ascites
1
2016
5
0.170
Why?
Canada
1
2016
55
0.170
Why?
Fraud
1
2016
10
0.170
Why?
Paracentesis
1
2016
4
0.170
Why?
Quality Control
1
2016
48
0.170
Why?
Safety
1
2016
57
0.170
Why?
Interferons
1
2016
17
0.170
Why?
Eclampsia
1
2016
2
0.170
Why?
Psychometrics
1
2018
284
0.170
Why?
HELLP Syndrome
1
2016
2
0.170
Why?
Pre-Eclampsia
1
2016
8
0.170
Why?
Drug Approval
1
2016
33
0.170
Why?
Time Factors
3
2016
1894
0.160
Why?
Hydrogen-Ion Concentration
1
2016
172
0.160
Why?
Benchmarking
1
2015
28
0.160
Why?
Directive Counseling
1
2015
15
0.160
Why?
Hospitalization
2
2016
330
0.160
Why?
Diffusion of Innovation
1
2015
42
0.160
Why?
Benzazepines
1
2015
10
0.160
Why?
Isoquinolines
1
2015
17
0.160
Why?
Deficiency Diseases
1
2015
2
0.160
Why?
Adolescent
3
2020
2591
0.160
Why?
Administration, Oral
1
2015
164
0.160
Why?
Liver Failure
1
2015
13
0.160
Why?
Zinc
1
2015
39
0.150
Why?
Kidney Failure, Chronic
1
2017
168
0.150
Why?
Treatment Failure
2
2017
186
0.150
Why?
Severity of Illness Index
1
2020
1220
0.150
Why?
Indoles
1
2015
68
0.150
Why?
Comorbidity
4
2018
555
0.150
Why?
Phenotype
1
2015
360
0.150
Why?
Off-Label Use
1
2014
6
0.150
Why?
Hospitalists
1
2014
6
0.150
Why?
African Americans
1
2021
739
0.140
Why?
Randomized Controlled Trials as Topic
1
2016
357
0.140
Why?
Internship and Residency
1
2016
182
0.140
Why?
Multivariate Analysis
2
2015
390
0.140
Why?
Health Care Costs
1
2014
79
0.140
Why?
Cooperative Behavior
1
2014
88
0.140
Why?
Drug Eruptions
1
2013
18
0.130
Why?
Hematologic Diseases
1
2013
18
0.130
Why?
Viral Nonstructural Proteins
3
2017
9
0.130
Why?
Gastrointestinal Diseases
1
2013
43
0.130
Why?
Monitoring, Immunologic
1
2012
2
0.130
Why?
Quality of Health Care
1
2014
134
0.130
Why?
Drug Combinations
3
2017
86
0.130
Why?
Immunosuppression
1
2012
38
0.130
Why?
Predictive Value of Tests
2
2017
617
0.120
Why?
Cost of Illness
1
2011
61
0.120
Why?
Drug Carriers
1
2010
9
0.120
Why?
CD4-Positive T-Lymphocytes
1
2012
219
0.110
Why?
Models, Statistical
1
2011
140
0.110
Why?
Polymerase Chain Reaction
1
2010
208
0.110
Why?
Odds Ratio
1
2010
328
0.100
Why?
Prevalence
1
2011
533
0.100
Why?
Sensitivity and Specificity
1
2011
592
0.100
Why?
Fluorenes
2
2019
3
0.100
Why?
Hemoglobins
1
2008
76
0.090
Why?
Clinical Trials as Topic
1
2009
382
0.090
Why?
Cross-Sectional Studies
2
2021
915
0.080
Why?
Hospital Costs
2
2016
74
0.070
Why?
Non-alcoholic Fatty Liver Disease
1
2019
4
0.050
Why?
Quality-Adjusted Life Years
1
2019
23
0.050
Why?
Waiting Lists
1
2019
19
0.050
Why?
Tissue and Organ Procurement
1
2019
36
0.050
Why?
Liver Diseases, Alcoholic
1
2019
42
0.050
Why?
Insurance, Major Medical
1
2018
1
0.050
Why?
International Normalized Ratio
1
2018
32
0.050
Why?
Registries
1
2019
195
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2017
40
0.050
Why?
Uridine Monophosphate
1
2017
2
0.050
Why?
Genetic Variation
1
2017
117
0.040
Why?
Decision Support Techniques
1
2017
54
0.040
Why?
Delivery of Health Care, Integrated
1
2017
30
0.040
Why?
Serine Proteases
1
2016
7
0.040
Why?
Internal Medicine
1
2016
30
0.040
Why?
Career Choice
1
2016
32
0.040
Why?
Patient-Centered Care
1
2017
61
0.040
Why?
Pain Management
1
2018
135
0.040
Why?
Cost Savings
1
2016
39
0.040
Why?
Quality Indicators, Health Care
1
2016
44
0.040
Why?
Mental Disorders
1
2018
202
0.040
Why?
Patient Care Team
1
2017
140
0.040
Why?
Curriculum
1
2016
153
0.040
Why?
Early Diagnosis
1
2015
76
0.040
Why?
Reproducibility of Results
1
2018
857
0.040
Why?
Statistics, Nonparametric
1
2015
162
0.040
Why?
Hospital Mortality
1
2016
178
0.040
Why?
Kaplan-Meier Estimate
1
2015
226
0.040
Why?
Databases, Factual
1
2016
357
0.040
Why?
Linear Models
1
2015
277
0.040
Why?
Drug Industry
1
2014
30
0.040
Why?
Clinical Competence
1
2016
268
0.030
Why?
Acquired Immunodeficiency Syndrome
1
2014
100
0.030
Why?
Guideline Adherence
1
2014
81
0.030
Why?
Survival Rate
1
2015
464
0.030
Why?
Inpatients
1
2014
132
0.030
Why?
Immunoassay
1
2012
42
0.030
Why?
Immunity, Cellular
1
2012
70
0.030
Why?
Probability
1
2012
107
0.030
Why?
Disease Progression
1
2015
843
0.030
Why?
Immunosuppressive Agents
1
2012
167
0.030
Why?
Postoperative Complications
1
2012
1059
0.020
Why?
Reau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description